Видео ютуба по тегу Kras Signalling In Cancer

Cancer cell biology: mutated KRAS & reciprocal signalling
Cancer cell biology: mutated KRAS & reciprocal signalling
Cancer cell biology: mutated KRAS & reciprocal signalling
Cancer cell biology: mutated KRAS & reciprocal signalling
Signaling pathways in intestinal homeostasis and colorectal cancer KRAS at centre stage
Signaling pathways in intestinal homeostasis and colorectal cancer KRAS at centre stage
KRAS mutation
KRAS mutation
RAS & Cancer: A Mighty Mutation
RAS & Cancer: A Mighty Mutation
Ras-MAPK pathway | Ras-MAPK in cancer | The MAP Kinase (MAPK) signalling pathway
Ras-MAPK pathway | Ras-MAPK in cancer | The MAP Kinase (MAPK) signalling pathway
Ras Raf MAPK Pathway and Cancer | Mutations, Cancer Pathogenesis, and Chemotherapy
Ras Raf MAPK Pathway and Cancer | Mutations, Cancer Pathogenesis, and Chemotherapy
What is a KRAS mutation?
What is a KRAS mutation?
The Role of KRas in Cancer
The Role of KRas in Cancer
Understanding NSCLC Treatment When You Have a KRAS Mutation
Understanding NSCLC Treatment When You Have a KRAS Mutation
Clarifying the mechanism of EGFR inhibition in KRAS G13D colorectal cancer
Clarifying the mechanism of EGFR inhibition in KRAS G13D colorectal cancer
Deciphering RAS/MAPK signalling in cancer
Deciphering RAS/MAPK signalling in cancer
Resistance in BRAF and KRAS Mutant Cancers - by Ryan Corcoran, MD, PhD
Resistance in BRAF and KRAS Mutant Cancers - by Ryan Corcoran, MD, PhD
Innovative Approaches to Investigating KRAS Therapeutics with Biochemical and Cell Based Assays 2
Innovative Approaches to Investigating KRAS Therapeutics with Biochemical and Cell Based Assays 2
The case for separating G12D mutations in studying KRAS-mutant PDAC
The case for separating G12D mutations in studying KRAS-mutant PDAC
Case 3: KRAS-Mutated Metastatic Colon Cancer
Case 3: KRAS-Mutated Metastatic Colon Cancer
We're Finally Beginning to Crack the KRAS Nut in Colorectal Cancer
We're Finally Beginning to Crack the KRAS Nut in Colorectal Cancer
Treatment strategies for KRAS-mutant NSCLC with co-mutations
Treatment strategies for KRAS-mutant NSCLC with co-mutations
Challenges of KRAS-targeting for lung cancer therapy
Challenges of KRAS-targeting for lung cancer therapy